GASTOMAC

This brand name is authorized in Nigeria.

Active ingredients

The drug GASTOMAC contains a combination of these active pharmaceutical ingredients (APIs):

1	Magaldrate UNII 6V88E24N5T - MAGALDRATE
	Magaldrate is a common antacid drug that is used for the treatment of duodenal and gastric ulcers, esophagitis from gastroesophageal reflux.
	Read more about Magaldrate
2	Simethicone UNII 92RU3N3Y1O - DIMETHICONE
	Simethicone is a chemically inert, non-systemic gastric defoaming agent that works by altering the elasticity of interfaces of mucus-embedded bubbles in the gastrointestinal tract. The gas bubbles are thus broken down or coalesced and in this form gas is more easily eliminated through eructation or passing flatus.
	Read more about Simethicone

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A11-0877	Suspension	GASTOMAC ANTACID SUSPENSION SUSP 540 mg; 100 mg 180ML	47 CMS-PP-283389 GASTOMAC ANTACID SUSPENSION MAGALDRATE, SIMETHICONE EACH 5ML CONTAINS: MAGALDRATE USP 540MG. SIMETHICONE USP 100MG. A11-0877 Drugs Nigerian Products 180ML,200ML OTC 3/3/2023 STERLING BIOPHARMA LIMITED, ,FEMI ASIWAJU CLOSE OJODU ESTATE OJODU LAGOS 8070627212 sterlingbiopharma@yahoo.com NALIS PHARMACEUTICALS LIMITED, PLOT R67-R68, NEKEDE-NAZE INDUSTRIAL CLUSTER, NEKEDE, OWERRI, IMO STATE, Nigeria	25/05/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A02AF01	Magaldrate and antiflatulents	A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02A Antacids → A02AF Antacids with antiflatulents
Discover more medicines within A02AF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A11-0877